AKT1 and neoplasm: Previous studies have shown that EGFL6 can activate Wnt/β-catenin and AKT/ERK signaling pathways, particularly EGFL6 plays a role in tumor angiogenesis through the ERK/AKT signaling pathway, which is associated with tumor occurrence, growth, and metastasis (Kang et al., 2020).